Hantech Bio-Technology Co., Ltd. (TPEX:1294)
Taiwan
· Delayed Price · Currency is TWD 79.40
-0.10 (-0.13%)
Apr 29, 2026, 1:30 PM CST
Hantech Bio-Technology Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Market Capitalization | 2,400 | 2,382 | 2,572 | 2,024 | 816 | - | Upgrade
|
| Market Cap Growth | -8.44% | -7.40% | 27.10% | 148.03% | - | - | Upgrade
|
| Enterprise Value | 2,195 | 2,211 | 2,421 | 2,016 | 858 | - | Upgrade
|
| Last Close Price | 79.40 | 78.80 | 81.06 | 69.64 | 28.26 | - | Upgrade
|
| PE Ratio | 17.49 | 17.13 | 16.52 | 13.66 | 17.19 | - | Upgrade
|
| PS Ratio | 3.08 | 3.06 | 3.44 | 3.24 | 2.70 | - | Upgrade
|
| PB Ratio | 2.88 | 2.86 | 3.13 | 5.04 | 3.04 | - | Upgrade
|
| P/TBV Ratio | 2.91 | 2.89 | 3.17 | 5.13 | 3.07 | - | Upgrade
|
| P/FCF Ratio | 16.53 | 16.41 | 20.40 | - | - | - | Upgrade
|
| P/OCF Ratio | 14.94 | 14.83 | 17.06 | 10.55 | 12.92 | - | Upgrade
|
| EV/Sales Ratio | 2.82 | 2.84 | 3.24 | 3.23 | 2.84 | - | Upgrade
|
| EV/EBITDA Ratio | 10.40 | 10.47 | 10.95 | 10.17 | 12.52 | - | Upgrade
|
| EV/EBIT Ratio | 12.69 | 12.78 | 12.26 | 10.86 | 15.10 | - | Upgrade
|
| EV/FCF Ratio | 15.12 | 15.23 | 19.20 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.16 | 0.16 | 0.19 | 0.82 | 0.44 | 0.81 | Upgrade
|
| Debt / EBITDA Ratio | 0.62 | 0.62 | 0.70 | 1.61 | 1.57 | 2.50 | Upgrade
|
| Debt / FCF Ratio | 0.91 | 0.91 | 1.26 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.25 | -0.25 | -0.27 | 0.41 | 0.16 | 0.33 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.98 | -0.98 | -1.01 | 0.82 | 0.64 | 1.15 | Upgrade
|
| Net Debt / FCF Ratio | -1.43 | -1.43 | -1.77 | -1.60 | -2.22 | -1.67 | Upgrade
|
| Asset Turnover | 0.68 | 0.68 | 0.73 | 0.89 | 0.71 | 0.70 | Upgrade
|
| Inventory Turnover | 5.48 | 5.48 | 5.87 | 6.27 | 6.85 | 6.66 | Upgrade
|
| Quick Ratio | 1.93 | 1.93 | 2.41 | 1.14 | 1.29 | 1.65 | Upgrade
|
| Current Ratio | 2.40 | 2.40 | 2.78 | 1.52 | 1.64 | 2.01 | Upgrade
|
| Return on Equity (ROE) | 16.83% | 16.83% | 25.43% | 44.04% | 20.54% | 19.11% | Upgrade
|
| Return on Assets (ROA) | 9.46% | 9.46% | 12.04% | 16.53% | 8.37% | 7.23% | Upgrade
|
| Return on Invested Capital (ROIC) | 22.35% | 22.77% | 27.14% | 33.86% | 16.46% | 16.34% | Upgrade
|
| Return on Capital Employed (ROCE) | 18.80% | 18.80% | 21.30% | 26.30% | 15.10% | 12.90% | Upgrade
|
| Earnings Yield | 5.79% | 5.84% | 6.05% | 7.32% | 5.82% | - | Upgrade
|
| FCF Yield | 6.05% | 6.09% | 4.90% | -5.04% | -2.41% | - | Upgrade
|
| Dividend Yield | 3.66% | - | 3.59% | 1.00% | 2.15% | - | Upgrade
|
| Payout Ratio | 62.88% | 62.88% | 12.47% | 11.37% | - | 24.75% | Upgrade
|
| Buyback Yield / Dilution | -4.66% | -4.66% | -3.38% | -8.45% | -7.98% | -2.60% | Upgrade
|
| Total Shareholder Return | -0.99% | -4.66% | 0.20% | -7.45% | -5.83% | -2.60% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.